June 29 (Reuters) - RELIEF THERAPEUTICS HOLDING SA RLFB.S :
* RELIEF AND APR APPLIED PHARMA RESEARCH SIGN AND CLOSE
DEFINITIVE
AGREEMENT FOR RELIEF TO ACQUIRE ALL OUTSTANDING SHARES OF APR
* UNDER TERMS OF AGREEMENT, APR'S SHAREHOLDERS HAVE RECEIVED
FROM
RELIEF CHF 21.5 MILLION IN CASH AND WILL FURTHER RECEIVE CHF 45
MILLION IN RELIEF COMMON REGISTERED SHARES (WHEN ISSUED AND
LISTED)
* APR SHAREHOLDERS ARE ALSO ELIGIBLE TO RECEIVE ADDITIONAL
CONTINGENT PAYMENTS IN A COMBINATION OF CASH AND RELIEF COMMON
REGISTERED SHARES UPON ACHIEVEMENT OF PRE-AGREED MILESTONES
* RELIEF PLANS TO OPTIMIZE APR'S PRODUCT PORTFOLIO AND
OUT-LICENSING PROGRAMS
Source text for Eikon: ID:nEQbmzPDxa
Further company coverage: RLFB.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))